Evidence map›Paper›PMID 36624496›Full record

Observational studyBMC public health2023

When schools were open for in-person teaching during the COVID-19 pandemic - the nordic experience on control measures and transmission in schools during the delta wave.

Torill Alise Rotevatn, Karin Nygård, Laura Espenhain, Rebecca Legarth, Karina Lauenborg Møller, Emmi Sarvikivi, Otto Helve, Guðrún Aspelund, Annika Ersson, Marie Nordahl and 3 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 5 countries.

Torill Alise RotevatnNorwegian Institute of Public Health, Oslo, Norway.
Karin NygårdNorwegian Institute of Public Health, Oslo, Norway.
Laura EspenhainStatens Serum Institut, Copenhagen, Denmark.
Rebecca LegarthStatens Serum Institut, Copenhagen, Denmark.
Karina Lauenborg MøllerStatens Serum Institut, Copenhagen, Denmark.
Emmi SarvikiviFinnish Institute for Health and Welfare, Helsinki, Finland.
Otto HelveFinnish Institute for Health and Welfare, Helsinki, Finland.
Guðrún AspelundThe Directorate of Health, Reykjavik, Iceland.
Annika ErssonThe Public Health Agency of Sweden, Stockholm, Sweden.
Marie NordahlThe Public Health Agency of Sweden, Stockholm, Sweden.
Margrethe Greve-IsdahlNorwegian Institute of Public Health, Oslo, Norway.
Elisabeth Astrup *Norwegian Institute of Public Health, Oslo, Norway.
Tone Bjordal Johansen *Norwegian Institute of Public Health, Oslo, Norway. tone.johansen@fhi.no.
Norwegian Institute of Public Health · NOStatens Serum Institut · DKFinnish Institute for Health and Welfare · FIPublic Health Agency of Sweden · SEDirectorate of Health · IS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExtensive measures to control spread of SARS-CoV-2 have led to limited access to education for millions of children and adolescents during the COVID-19 pandemic. Education and access to schools is vital for children and adolescents' learning, health, and wellbeing. Based on high vaccine uptake and low incidence levels, the Nordic countries (Denmark, Finland, Iceland, Norway and Sweden) decided to start the academic year 2021/22 with schools open for in-person teaching and moderate mitigation measures. We describe trends in SARS-CoV-2 infections and vaccination coverage among students during the first 12 weeks of the fall semester.

methodsIn this multinational, retrospective, observational study, we have used surveillance and registry data from each of the Nordic countries to describe vaccine uptake (≥12 years), infection incidence (whole population) and transmission of SARS-CoV-2 among students. The study period, week 30 to 41 (Jul 26th - Oct 17th), represents the autumn semester from immediately before school started until fall break. In addition, we collected information on mitigation measures applied by the respective countries.

resultsThere were slight variations between the countries regarding existing infection prevention and control (IPC) measures, testing strategies and vaccination start-up among adolescents. All countries had high vaccine uptake in the adult population, while uptake varied more in the younger age groups. Incidence in the school-aged population differed between countries and seemed to be influenced by both vaccine uptake and test activity. Infection clusters among school-aged children were described for Denmark and Norway, and the number of clusters per week reflected the incidence trend of the country. Most events consisted of only 1-2 cases. Larger clusters appeared more frequently in the higher grades in Norway and in lower grades in Denmark.

conclusionData from the Nordic countries indicate that vaccination of adults and adolescents, in addition to mitigation measures, enabled full in-person learning. As SARS-CoV-2 infection does not represent a severe medical risk for most children as previously thought, measures targeting this group should be carefully adjusted and kept at a minimum. Our data add to the evidence on incidence and transmission of SARS-CoV-2 among students in schools open for in-person teaching, and may be valuable for decision makers worldwide.

Indexed as

COVID-19AdolescentAdultChildHumansPandemicsRetrospective StudiesSARS-CoV-2SchoolsCOVID-19Incidence trendsMitigation measuresSARS-CoV-2SchoolsVaccination

Identifiers

PMID36624496
PMCPMC9828373
OpenAlexW4315436720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.